Tetrahydrocannabinol (THC)
Though both MARINOL and marijuana contain tetrahydrocannabinol (THC), there are differences between the two.
MARINOL | Medical Marijuana | |
---|---|---|
Contains THC | Yes | Yes |
Federally regulated prescription drug | Yes | No |
Manufactured under controlled conditions | Yes | No |
Rigorous safety and purity standards | Yes | Lack of information |
Clinical trials conducted on safety and efficacy | Yes | Lack of information |
Legal in every state | Yes | No |
Covered by many insurance plans | Yes | No |
INDICATION2
MARINOL® (dronabinol) is a cannabinoid indicated in adults for the treatment of:
IMPORTANT SAFETY INFORMATION2
CONTRAINDICATIONS
MARINOL is contraindicated in patients with a known history of a hypersensitivity reaction to dronabinol or sesame oil. Reported hypersensitivity reactions to dronabinol capsules include lip swelling, hives, disseminated rash, oral lesions, skin burning, flushing, and throat tightness.
WARNINGS AND PRECAUTIONS
Neuropsychiatric Adverse Reactions
Hemodynamic Instability
Seizures
Multiple Substance Abuse
Paradoxical Nausea, Vomiting, or Abdominal Pain
ADVERSE REACTIONS
The most common adverse reactions in MARINOL clinical trials (≥3%) were: abdominal pain, abnormal thinking, dizziness, euphoria, nausea, paranoid reaction, somnolence, and vomiting.
Please click here for Full Prescribing Information for MARINOL Capsules.
INDICATION2
MARINOL® (dronabinol) is a cannabinoid indicated in adults for the treatment of:
IMPORTANT SAFETY INFORMATION2
CONTRAINDICATIONS
MARINOL is contraindicated in patients with a known history of a hypersensitivity reaction to dronabinol or sesame oil. Reported hypersensitivity reactions to dronabinol capsules include lip swelling, hives, disseminated rash, oral lesions, skin burning, flushing, and throat tightness.
WARNINGS AND PRECAUTIONS
Neuropsychiatric Adverse Reactions
Hemodynamic Instability
Seizures
Multiple Substance Abuse
Paradoxical Nausea, Vomiting, or Abdominal Pain
ADVERSE REACTIONS
The most common adverse reactions in MARINOL clinical trials (≥3%) were: abdominal pain, abnormal thinking, dizziness, euphoria, nausea, paranoid reaction, somnolence, and vomiting.
Please click here for Full Prescribing Information for MARINOL Capsules.
You are leaving the MARINOL (dronabinol) website and connecting to a site that is not under the control of AbbVie. AbbVie is not responsible for the contents of any such site or any further links from such site. AbbVie is providing these links to you only as a convenience and the inclusion of any link does not imply the endorsement of the linked site by AbbVie. You should also be aware that the linked site may be governed by its own set of terms and conditions and privacy policy for which AbbVie has no responsibility.
By selecting "Yes" below, you certify that you are a Healthcare Professional and that you wish to proceed to the Healthcare Professionals Only section on the AbbVie Medical Information site. Products or treatments described on this site are available in the U.S., but may not be available in all other countries. I am a licensed Healthcare Professional and wish to proceed to the Healthcare Professionals Only AbbVie Medical Information site.